Ann: Investor Webinar Notification - SPL Business Update, page-37

My overall impression is that Cheryl appears to be much more pragmatic that her predecessor. With her fresh pair of eyes she can see that Starpharma is not in the champions league, playing alongside big pharma. SPL is second tier and needs to compete in a different league.
Jackie and Rob Thomas couldn’t see that they were promoting a grand illusion, which is why they, and the company, were constantly being shafted (re AZ).
When Cheryl inks the first deal for cabazitaxel or irinotecan then the SP will start to recover. She has 9 months to score some goals and the kick off whistle has just been blown.

And no mention of a CR (not that I expected one today) - hurrah!